Toll Free: 1-888-928-9744
Published: Aug, 2014 | Pages:
23 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Monosol Rx, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Monosol Rx, LLC - Product Pipeline Review - 2014', provides an overview of the Monosol Rx, LLC's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Monosol Rx, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Monosol Rx, LLC including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Monosol Rx, LLC's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Monosol Rx, LLC's pipeline products Reasons to buy - Evaluate Monosol Rx, LLC's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Monosol Rx, LLC in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Monosol Rx, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Monosol Rx, LLC and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Monosol Rx, LLC - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Monosol Rx, LLC and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Monosol Rx, LLC Snapshot 4 Monosol Rx, LLC Overview 4 Key Information 4 Key Facts 4 Monosol Rx, LLC - Research and Development Overview 5 Key Therapeutic Areas 5 Monosol Rx, LLC - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Combination Treatment Modalities 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Monosol Rx, LLC - Pipeline Products Glance 12 Monosol Rx, LLC - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Monosol Rx, LLC - Drug Profiles 13 (rizatriptan benzoate + ondansetron hydrochloride) 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 montelukast sodium 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 rizatriptan benzoate 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 testosterone undecanoate 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Monosol Rx, LLC - Pipeline Analysis 17 Monosol Rx, LLC - Pipeline Products by Target 17 Monosol Rx, LLC - Pipeline Products by Route of Administration 18 Monosol Rx, LLC - Pipeline Products by Molecule Type 19 Monosol Rx, LLC - Pipeline Products by Mechanism of Action 20 Monosol Rx, LLC - Locations And Subsidiaries 21 Head Office 21 Other Locations & Subsidiaries 21 Appendix 22 Methodology 22 Coverage 22 Secondary Research 22 Primary Research 22 Expert Panel Validation 22 Contact Us 23 Disclaimer 23
List of Tables Monosol Rx, LLC, Key Information 4 Monosol Rx, LLC, Key Facts 4 Monosol Rx, LLC - Pipeline by Indication, 2014 6 Monosol Rx, LLC - Pipeline by Stage of Development, 2014 7 Monosol Rx, LLC - Monotherapy Products in Pipeline, 2014 8 Monosol Rx, LLC - Combination Treatment Modalities in Pipeline, 2014 9 Monosol Rx, LLC - Partnered Products in Pipeline, 2014 10 Monosol Rx, LLC - Partnered Products/ Combination Treatment Modalities, 2014 11 Monosol Rx, LLC - Preclinical, 2014 12 Monosol Rx, LLC - Pipeline by Target, 2014 17 Monosol Rx, LLC - Pipeline by Route of Administration, 2014 18 Monosol Rx, LLC - Pipeline by Molecule Type, 2014 19 Monosol Rx, LLC - Pipeline Products by Mechanism of Action, 2014 20 Monosol Rx, LLC, Other Locations 21
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.